Here are the top stories from the last week:

Industry Updates

New York and Northeast states unite on COVID vaccineguidance
Nine states are creating unified COVID-19 vaccination recommendations throughthe Northeast Public Health Collaborative.
Read article »

California and West Coast states break from CDC onvaccines
The states reject the CDC's new vaccine guidance and issue their own, citingthe need to protect scientific integrity.
Read article »

Patients face barriers to care as adoption by providerslags behind, study finds
A national survey of 1,501 U.S. consumers by RXNT uncovered a sharp disconnect between available technology and its use in everyday health care, significantly impacting patients.
Read article »

MinuteClinic Primary Care expands access amid shortage of primary care physicians
MinuteClinic is evolving into a primary care model, while continuing to offer walk-in sick care.
Read article »

Clinicians report patient experience key but lack ability to help improve it, says Surescripts study
Prescription affordability, coverage, and prior authorization requirements impact patient experience.
Read article »

NACDS says pharmacist services vital to success of Rural Health Transformation Program
Pharmacies can help the program achieve its strategic goals.
Read article »

CMS launches landmark $50 billion Rural Health Transformation Program
New federal program aims to transform rural health care nationwide.
Read article »

NCPA Regional Chain Advisory Group in D.C. to lobby Congress, meet with CMS and HHS officials
The group had over 30 meetings with various representatives and senators to discuss drug pricing issues and the role of independent pharmacies as community health care centers.
Read article »

Treatment & Technology Updates

Amneal receives FDA OK for generic Xyrem
The Food and Drug Administration has approved Amneal's sodium oxybate oral solution 500 mg/ml, which is a generic of Jazz Pharmaceuticals' Xyrem.
Read article »

Camber unveils bexarotene capsules
Camber is introducing bexarotene capsules, indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy.
Read article »